CLIFTON, N.J., May 20, 2025 /PRNewswire/ — CS Analytical Laboratory, the world’s only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and testing services specifically for drug product and medical device package systems, is excited to announce that the major expansion program ASTM D4169-23 and ISTA Package Distribution Testing services is now fully operational. Based upon the installation and qualification of new equipment to include a custom-made, large-scale Lansmont Vibration test platform fitted with a uniquely designed Abbess Temperature and Altitude chamber that enables comprehensive, multimodal, and real-time simulated distribution testing for unique, high-risk, or high-value product types and package systems. In addition, CS Analytical will continue to offer its suite of services specific to routine ISTA Series 2/3/6 and ASTM D4169-23 distribution testing services to their pharmaceutical, biotech, and medical device clients.
As noted by Brandon Zuralow, CS Analytical COO, “To remain relevant for our client base, we must continue to offer services that enable clients to meet the ever-changing and often complicated regulatory requirements and best practices for their container and package systems. The CS Analytical Team is committed to this endeavor as evidenced by this expansion to our current service offering.”
Traditionally, these environmental factors would be independently evaluated through conditioning, vibration, and altitude testing. For certain products such as cell and gene therapies, with their small-batch / high-value nature and unique shipment requirements, or proteinaceous products susceptible to aggregation, testing to current standards may risk over- or under-testing relative to what is experienced in the real world. Evaluating these factors in tandem provides a more accurate picture of the performance of the product-package under realistic transport conditions.
“Package distribution testing for these types of products can be challenging. Existing standards may result in over- or under-testing relative to real world distribution networks. For clients in this position, real-world, non-simulated testing is often performed, which is both time and cost intensive,” commented Alex Goldberg, CS Analytical Laboratory Analyst and Project Lead. “The ability to simulate this in the laboratory is a gamechanger for efficiency, as well as science and risk-based product-package development.”
Currently, many companies that require this type of testing are performing it real-time by sending actual product through existing shipment channels. This quickly becomes time and cost prohibitive, especially when design changes are required. Having a service provider that can replicate this type of testing in a laboratory setting will offer huge time and cost savings. Additionally, since the equipment is fully programmable, clients who have mapped the actual temperature, pressure, and vibratory profiles of their distribution channels can recreate them in the lab, simulating the exact stressors experienced in the field.
The CS Analytical Team currently offers complete ASTM D4169-23 and ISTA Certified testing for common or unique primary, secondary, and tertiary packaging components and systems. However, distribution testing is just one element of successful product-package development and validation. CS Analytical offers a host of support and complementary testing programs that ensure all aspects of the regulatory requirements are met for any type of container system in a comprehensive manner. Whether a traditional solid oral dose in an HDPE bottle, a unique drug delivery system, a challenging and oversized IV bag system, the CS Analytical Team has the knowledge and hands-on experience to develop a qualification test program that ensures all development goals and regulatory compliance factors are met.
About CS Analytical Laboratory
The world’s only cGMP, FDA-registered contract laboratory exclusively designed and dedicated to container testing for the pharmaceutical, biotechnology, and medical device industries, the CS Analytical Team includes world-leading experts and thought-leaders on FDA and EU regulatory expectations and USP and EP primary package testing requirements inclusive of container closure integrity (CCI) testing (CCIT). Test services include CCI method development, validation, and analysis, USP/EP/JP physical and physicochemical testing, and Comprehensive and Complementary services for all common or unique primary packaging components and systems inclusive of glass, plastic, elastomeric, and more. CS Analytical is the single source to ensure a regulated industry product-package system meets strict, complex, and ever-changing regulatory requirements.